Coloplast A/S (CLPBF)
Coloplast A/S Statistics
Share Statistics
Coloplast A/S has 225M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 225M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 154.18M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 38.7 and the forward PE ratio is null. Coloplast A/S's PEG ratio is 33.04.
| PE Ratio | 38.7 |
| Forward PE | n/a |
| PS Ratio | 7.23 |
| Forward PS | null |
| PB Ratio | 10.9 |
| P/FCF Ratio | 137.68 |
| PEG Ratio | 33.04 |
Enterprise Valuation
Coloplast A/S has an Enterprise Value (EV) of 217.35B.
| EV / Sales | 8.04 |
| EV / EBITDA | 25.63 |
| EV / EBIT | 78.58 |
| EV / FCF | 153.06 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of 1.26.
| Current Ratio | 1.02 |
| Quick Ratio | 0.66 |
| Debt / Equity | 1.26 |
| Debt / EBITDA | 2.67 |
| Debt / FCF | 15.94 |
| Interest Coverage | 9.21 |
Financial Efficiency
Return on Equity is 28.16% and Return on Invested Capital is 13.38%.
| Return on Equity | 28.16% |
| Return on Assets | 10.51% |
| Return on Invested Capital | 13.38% |
| Revenue Per Employee | $1.63M |
| Profits Per Employee | $303.82K |
| Employee Count | 16,628 |
| Asset Turnover | 0.56 |
| Inventory Turnover | 2.39 |
Taxes
| Income Tax | 1.34B |
| Effective Tax Rate | 21% |
Stock Price Statistics
The stock price has increased by -23.66% in the last 52 weeks. The beta is 0.6, so Coloplast A/S's price volatility has been higher than the market average.
| Beta | 0.6 |
| 52-Week Price Change | -23.66% |
| 50-Day Moving Average | 105.24 |
| 200-Day Moving Average | 118.78 |
| Relative Strength Index (RSI) | 25.49 |
| Average Volume (20 Days) | 96 |
Income Statement
In the last 12 months, Coloplast A/S had revenue of 27.03B and earned 5.05B in profits. Earnings per share was 22.46.
| Revenue | 27.03B |
| Gross Profit | 18.27B |
| Operating Income | 7.32B |
| Net Income | 5.05B |
| EBITDA | 8.48B |
| EBIT | 7.19B |
| Earnings Per Share (EPS) | 22.46 |
Balance Sheet
The company has 788M in cash and 22.63B in debt, giving a net cash position of -21.84B.
| Cash & Cash Equivalents | 788M |
| Total Debt | 22.63B |
| Net Cash | -21.84B |
| Retained Earnings | 15.39B |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was 2.77B and capital expenditures -1.35B, giving a free cash flow of 1.42B.
| Operating Cash Flow | 2.77B |
| Capital Expenditures | -1.35B |
| Free Cash Flow | 1.42B |
| FCF Per Share | 6.31 |
Margins
Gross margin is 67.59%, with operating and profit margins of 27.08% and 18.69%.
| Gross Margin | 67.59% |
| Operating Margin | 27.08% |
| Pretax Margin | 23.66% |
| Profit Margin | 18.69% |
| EBITDA Margin | 31.37% |
| EBIT Margin | 27.08% |
| FCF Margin | 5.25% |
Dividends & Yields
CLPBF pays an annual dividend of $5.45, which amounts to a dividend yield of 2.58%.
| Dividend Per Share | $5.45 |
| Dividend Yield | 2.58% |
| Dividend Growth (YoY) | -0.91% |
| Payout Ratio | 170.78% |
| Earnings Yield | 2.58% |
| FCF Yield | 0.73% |
Analyst Forecast
Currently there are no analyst rating for CLPBF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Dec 26, 2012. It was a forward split with a ratio of 5:1.
| Last Split Date | Dec 26, 2012 |
| Split Type | forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |